Literature DB >> 15477762

Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis.

Ping Zhu1, Evamaria Huber, Franz Kiefer, Martin Göttlicher.   

Abstract

Inappropriate control of expression of genetic information is the cause of many forms of cancer. Aberrant transcriptional repression by recruitment of histone deacetylases (HDACs) is a key step in pathogenesis of myeloid leukemia. We recently reported that development of colonic cancer involves alterations in the transcriptional repression machinery by increased expression of HDAC2 upon loss of the APC tumor suppressor. Increased expression of HDAC2 is essential for prevention of apoptosis of HT-29 colonic cancer cells. We now discuss whether HDAC2 also plays a role for aberrant cell cycle regulation and expression of the p21(Cip/Waf) cell cycle inhibitor. Whereas inhibition of HDACs by valproic acid or trichostatin A increases p21 expression, selective interference with HDAC2 by siRNA transfection or reconstitution of wildtype APC does not affect p21 expression. Likewise, treatment of HT-29 cells with the HDAC inhibitor valproic acid leads to a moderate inhibition of cell cycle progression in the G1 phase whereas interference with HDAC2 expression does not. Thus, HDAC2 appears to serve a preferential role in the prevention of apoptosis and not in cell cycle control similar to the specific importance of HDAC1 for cell cycle regulation or HDAC 9 for the stress response of the heart.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477762     DOI: 10.4161/cc.3.10.1195

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

1.  HDAC2 regulates cell proliferation, cell cycle progression and cell apoptosis in esophageal squamous cell carcinoma EC9706 cells.

Authors:  Shenglei Li; Feng Wang; Yunhui Qu; Xiaoqi Chen; Ming Gao; Jianping Yang; Dandan Zhang; Na Zhang; Wencai Li; Hongtao Liu
Journal:  Oncol Lett       Date:  2016-11-25       Impact factor: 2.967

2.  Peptide arrays identify isoform-selective substrates for profiling endogenous lysine deacetylase activity.

Authors:  Zachary A Gurard-Levin; Kristopher A Kilian; Joohoon Kim; Katinka Bähr; Milan Mrksich
Journal:  ACS Chem Biol       Date:  2010-09-17       Impact factor: 5.100

3.  SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging.

Authors:  Philipp Oberdoerffer; Shaday Michan; Michael McVay; Raul Mostoslavsky; James Vann; Sang-Kyu Park; Andrea Hartlerode; Judith Stegmuller; Angela Hafner; Patrick Loerch; Sarah M Wright; Kevin D Mills; Azad Bonni; Bruce A Yankner; Ralph Scully; Tomas A Prolla; Frederick W Alt; David A Sinclair
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

4.  Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos.

Authors:  Pengpeng Ma; Richard M Schultz
Journal:  Dev Biol       Date:  2008-04-18       Impact factor: 3.582

5.  Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators.

Authors:  Hui Yang; Tal Salz; Maria Zajac-Kaye; Daiqing Liao; Suming Huang; Yi Qiu
Journal:  FASEB J       Date:  2014-06-19       Impact factor: 5.191

Review 6.  Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer.

Authors:  Sophia N Ononye; Michael van Heyst; Eric M Falcone; Amy C Anderson; Dennis L Wright
Journal:  Pharm Pat Anal       Date:  2012-05

7.  A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.

Authors:  Roland H Stauber; Shirley K Knauer; Negusse Habtemichael; Carolin Bier; Britta Unruhe; Simona Weisheit; Stephanie Spange; Frank Nonnenmacher; Verena Fetz; Torsten Ginter; Sigrid Reichardt; Claus Liebmann; Günter Schneider; Oliver H Krämer
Journal:  Oncotarget       Date:  2012-01

8.  ING2 (inhibitor of growth protein-2) plays a crucial role in preimplantation development.

Authors:  Lin Zhou; Pei Wang; Juanjuan Zhang; Boon Chin Heng; Guo Qing Tong
Journal:  Zygote       Date:  2015-02-12       Impact factor: 1.442

Review 9.  Histone Deacetylase Inhibitors and Diabetic Kidney Disease.

Authors:  Mitchell J Hadden; Andrew Advani
Journal:  Int J Mol Sci       Date:  2018-09-05       Impact factor: 5.923

10.  Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.

Authors:  Marielle Dejligbjerg; Morten Grauslund; Thomas Litman; Laura Collins; Xiaozhong Qian; Michael Jeffers; Henri Lichenstein; Peter Buhl Jensen; Maxwell Sehested
Journal:  Mol Cancer       Date:  2008-09-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.